Withings ECG-app Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 685 participants.

Also called NCT05316350

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 685 participants (enrolled count) (from the registry)
Sponsor
  • Syntactx Registry lists this organization as a collaborator
  • Withings Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05316350
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05316350. Non-randomized; no masking; primary purpose basic science. Start 2022-07-15 (actual); primary completion 2023-08-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Withings ECG-app Study
Intervention (Device)
Electrocardiogram recording
Intervention (Device)
Electrocardiogram recording
Lead sponsor
Withings (class: industry)
Collaborator
Syntactx (class: research network)

Record details

Record id
cardio:ct-nct05316350
Content hash
34c5aa912b1071ef7ac693f006fa6c6f189c00bc925d09aedb9877e30d033b04